Cell Lysis & Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-20
Cell Lysis & Fractionation Market Trends and Forecast
The future of the global cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies. The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028 with a CAGR of 8.3% from 2023 to 2028. The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Cell Lysis & Fractionation Market by Segment
The study includes trends and forecast for the global cell lysis & fractionation market by product, cell type, application, end use industry, and region, as follows:
Cell Lysis & Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
? Enzymes
? Detergent Solutions
? Others
o Homogenizers
o Other Instruments
Cell Lysis & Fractionation Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell lysis & fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell lysis & fractionation companies profiled in this report include-
Q1. What is the cell lysis & fractionation market size?
Answer: The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028.
Q2. What is the growth forecast for cell lysis & fractionation market?
Answer: The global cell lysis & fractionation market is expected to grow with a CAGR of 8.3% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the cell lysis & fractionation market?
Answer:The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.
Q4. What are the major segments for cell lysis & fractionation market?
Answer: The future of the cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies.
Q5. Who are the key cell lysis & fractionation companies?
Answer: Some of the key cell lysis & fractionation companies are as follows:
Answer:Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
Q7. In cell lysis & fractionation market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global cell lysis & fractionation market by product ((consumables( kits and reagents (enzymes, detergent solutions, and others)), instruments (sonicators, homogenizers, and other instruments)), cell type (mammalian cells, microbial cells, and other cells), application (protein purification and isolation, nucleic acid isolation and purification, and others), end use industry (research laboratories and institutes, biopharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to cell lysis & fractionation market or related to cell lysis & fractionation companies, cell lysis & fractionation market size, cell lysis & fractionation market share, cell lysis & fractionation analysis, cell lysis & fractionation market growth, cell lysis & fractionation market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
The future of the global cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies. The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028 with a CAGR of 8.3% from 2023 to 2028. The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Cell Lysis & Fractionation Market by Segment
The study includes trends and forecast for the global cell lysis & fractionation market by product, cell type, application, end use industry, and region, as follows:
Cell Lysis & Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Consumables
? Enzymes
? Detergent Solutions
? Others
- Instruments
o Homogenizers
o Other Instruments
Cell Lysis & Fractionation Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Mammalian Cells
- Microbial Cells
- Others
- Protein Purification and Isolation
- Nucleic Acid Isolation and Purification
- Others
- Research Laboratories and Institutes
- Biopharmaceutical and Biotechnology Companies
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell lysis & fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell lysis & fractionation companies profiled in this report include-
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Miltenyi Biotec
- Becton Dickinson
- Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
- Research laboratories and institutes are expected to witness the highest growth over the forecast period due to increasing incidence of chronic disease and rising government investment for research.
- North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.
- Market Size Estimates: Cell lysis & fractionation market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Cell lysis & fractionation market size by various segments, such as product, cell type, application, end use industry, and region
- Regional Analysis: Cell lysis & fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, product, cell type, application, end use industry, and regions for the cell lysis & fractionation market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the cell lysis & fractionation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the cell lysis & fractionation market size?
Answer: The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028.
Q2. What is the growth forecast for cell lysis & fractionation market?
Answer: The global cell lysis & fractionation market is expected to grow with a CAGR of 8.3% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the cell lysis & fractionation market?
Answer:The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.
Q4. What are the major segments for cell lysis & fractionation market?
Answer: The future of the cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies.
Q5. Who are the key cell lysis & fractionation companies?
Answer: Some of the key cell lysis & fractionation companies are as follows:
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Miltenyi Biotec
- Becton Dickinson
Answer:Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
Q7. In cell lysis & fractionation market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global cell lysis & fractionation market by product ((consumables( kits and reagents (enzymes, detergent solutions, and others)), instruments (sonicators, homogenizers, and other instruments)), cell type (mammalian cells, microbial cells, and other cells), application (protein purification and isolation, nucleic acid isolation and purification, and others), end use industry (research laboratories and institutes, biopharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to cell lysis & fractionation market or related to cell lysis & fractionation companies, cell lysis & fractionation market size, cell lysis & fractionation market share, cell lysis & fractionation analysis, cell lysis & fractionation market growth, cell lysis & fractionation market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL CELL LYSIS & FRACTIONATION MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Cell Lysis & Fractionation Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Cell Lysis & Fractionation Market by Product
3.3.1: Consumables
3.3.1.1: Kits and Reagents
3.3.1.1.1: Enzymes
3.3.1.1.2: Detergent Solutions
3.3.1.1.3: Others
3.3.2: Instruments
3.3.2.1: Sonicators
3.3.2.2: Homogenizers
3.3.2.3.: Other Instruments
3.4: Global Cell Lysis & Fractionation Market by Cell Type
3.4.1: Mammalian Cells
3.4.2: Microbial Cells
3.4.3: Others
3.5: Global Cell Lysis & Fractionation Market by Application
3.5.1: Protein Purification and Isolation
3.5.2: Nucleic Acid Isolation and Purification
3.5.3: Others
3.6: Global Cell Lysis & Fractionation Market by End Use Industry
3.6.1: Research Laboratories and Institutes
3.6.2: Biopharmaceutical and Biotechnology Companies
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Cell Lysis & Fractionation Market by Region
4.2: North American Cell Lysis & Fractionation Market
4.2.1: North American Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.2.2: North American Cell Lysis & Fractionation Market by End Use Industry : Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.3: European Cell Lysis & Fractionation Market
4.3.1: European Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.3.2: European Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.4: APAC Cell Lysis & Fractionation Market
4.4.1: APAC Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.4.2: APAC Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.5: ROW Cell Lysis & Fractionation Market
4.5.1: ROW Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.5.2: ROW Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
5. COMPETITOR ANALYSIS
5.1: Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Product
6.1.2: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Cell Type
6.1.3: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Application
6.1.4: Growth Opportunities for the Global Cell Lysis & Fractionation Market by End Use Industry
6.1.5: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Region
6.2: Emerging Trends in the Global Cell Lysis & Fractionation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cell Lysis & Fractionation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Lysis & Fractionation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Merck KGaA
7.3: Bio-Rad Laboratories
7.4: Miltenyi Biotec
7.5: Becton Dickinson
2. GLOBAL CELL LYSIS & FRACTIONATION MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Cell Lysis & Fractionation Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Cell Lysis & Fractionation Market by Product
3.3.1: Consumables
3.3.1.1: Kits and Reagents
3.3.1.1.1: Enzymes
3.3.1.1.2: Detergent Solutions
3.3.1.1.3: Others
3.3.2: Instruments
3.3.2.1: Sonicators
3.3.2.2: Homogenizers
3.3.2.3.: Other Instruments
3.4: Global Cell Lysis & Fractionation Market by Cell Type
3.4.1: Mammalian Cells
3.4.2: Microbial Cells
3.4.3: Others
3.5: Global Cell Lysis & Fractionation Market by Application
3.5.1: Protein Purification and Isolation
3.5.2: Nucleic Acid Isolation and Purification
3.5.3: Others
3.6: Global Cell Lysis & Fractionation Market by End Use Industry
3.6.1: Research Laboratories and Institutes
3.6.2: Biopharmaceutical and Biotechnology Companies
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Cell Lysis & Fractionation Market by Region
4.2: North American Cell Lysis & Fractionation Market
4.2.1: North American Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.2.2: North American Cell Lysis & Fractionation Market by End Use Industry : Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.3: European Cell Lysis & Fractionation Market
4.3.1: European Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.3.2: European Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.4: APAC Cell Lysis & Fractionation Market
4.4.1: APAC Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.4.2: APAC Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
4.5: ROW Cell Lysis & Fractionation Market
4.5.1: ROW Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
4.5.2: ROW Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
5. COMPETITOR ANALYSIS
5.1: Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Product
6.1.2: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Cell Type
6.1.3: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Application
6.1.4: Growth Opportunities for the Global Cell Lysis & Fractionation Market by End Use Industry
6.1.5: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Region
6.2: Emerging Trends in the Global Cell Lysis & Fractionation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cell Lysis & Fractionation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Lysis & Fractionation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Merck KGaA
7.3: Bio-Rad Laboratories
7.4: Miltenyi Biotec
7.5: Becton Dickinson
